- Published on:
Havana, Feb 26 (Prensa Latina) President Miguel Diaz-Canel on Sunday described the beginning of a clinical trial on the drug NeuralCIM to treat mild or moderate Alzheimer's disease as a new challenge and contribution from Cuba's science.